BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15464676)

  • 21. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation.
    Ge L; Airoldi F; Iakovou I; Cosgrave J; Michev I; Sangiorgi GM; Montorfano M; Chieffo A; Carlino M; Corvaja N; Colombo A
    J Am Coll Cardiol; 2005 Aug; 46(4):613-20. PubMed ID: 16098424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment synergy of silicon carbide-coated stenting and abciximab for complex coronary artery lesions: clinical results of a single-center study.
    van der Vleuten PA; Wijpkema JS; van den Heuvel AF; Bosma CA; Jessurun GA; Tio RA
    Ital Heart J; 2004 Sep; 5(9):663-6. PubMed ID: 15568593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute and long-term outcomes of the novel side access (SLK-View) stent for bifurcation coronary lesions: a multicenter nonrandomized feasibility study.
    Ikeno F; Kim YH; Luna J; Condado JA; Colombo A; Grube E; Fitzgerald PJ; Park SJ; Yeung AC
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):198-206. PubMed ID: 16404749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results.
    Mirabella F; Francaviglia B; Capodanno D; Di Salvo ME; Galassi AR; Ussia GP; Capranzano P; Tamburino C
    J Invasive Cardiol; 2009 Apr; 21(4):145-50. PubMed ID: 19342750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A modified balloon crush approach improves side branch access and side branch stent apposition during crush stenting of coronary bifurcation lesions.
    Collins N; Dzavik V
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):365-71. PubMed ID: 16892432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: results of a multicenter registry.
    Sanmartin M; Baz JA; Lozano I; de la Torre JM; Hernandez JM; Bordes P; Mainar V; Mauri J; Iñiguez A
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):372-7. PubMed ID: 17195194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distal filter protection during percutaneous coronary intervention in native coronary arteries and saphenous vein grafts in patients with acute coronary syndromes.
    Pasquetto G; Reimers B; Favero L; Saccà S; Cernetti C; Napodano M; Piccolo P; Pascotto P
    Ital Heart J; 2003 Sep; 4(9):614-9. PubMed ID: 14635379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of stents and abciximab on survival from cardiogenic shock treated with percutaneous coronary intervention.
    Huang R; Sacks J; Thai H; Goldman S; Morrison DA; Barbiere C; Ohm J
    Catheter Cardiovasc Interv; 2005 May; 65(1):25-33. PubMed ID: 15800889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).
    Teirstein PS; Kao J; Watkins M; Tannenbaum MA; Laufer N; Chang M; Mehran R; Dangas G; Russell ME; Ellis SG; Stone GW
    Am J Cardiol; 2005 Aug; 96(4):500-5. PubMed ID: 16098300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
    Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
    Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The driver stent for coronary bifurcations: a clinical case and bench testing of provisional "culotte" side-branch stenting.
    Ormiston JA; Currie E; Panther MJ; Webster MW; O'Shaughnessy B
    J Invasive Cardiol; 2004 Feb; 16(2):1-3; quiz 4. PubMed ID: 14986621
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of final activated clotting time after transradial coronary stenting with maximal antiplatelet therapy.
    Bertrand OF; Rodés-Cabau J; Rinfret S; Larose E; Bagur R; Proulx G; Gleeton O; Costerousse O; De Larochellière R; Roy L
    Am J Cardiol; 2009 Nov; 104(9):1235-40. PubMed ID: 19840568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Provisional T-drug-eluting stenting technique for the treatment of bifurcation lesions: clinical, myocardial scintigraphy and (late) coronary angiographic results.
    Vigna C; Biondi-Zoccai G; Amico CM; Lanna P; Stanislao M; Santoro T; Valle G; Fanelli R; Loperfido F
    J Invasive Cardiol; 2007 Mar; 19(3):92-7. PubMed ID: 17341773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of coronary flow reserve and fractional flow reserve in patients with versus without diabetes mellitus and having elective percutaneous coronary intervention and abciximab therapy (from the PREDICT Trial).
    Kini AS; Kim MC; Moreno PR; Krishnan P; Ivan OC; Sharma SK
    Am J Cardiol; 2008 Mar; 101(6):796-800. PubMed ID: 18328843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The carina angle-new geometrical parameter associated with periprocedural side branch compromise and the long-term results in coronary bifurcation lesions with main vessel stenting only.
    Gil RJ; Vassilev D; Formuszewicz R; Rusicka-Piekarz T; Doganov A
    J Interv Cardiol; 2009 Dec; 22(6):E1-E10. PubMed ID: 19702678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results.
    López Mínguez JR; Nogales Asensio JM; Doncel Vecino LJ; Sandoval J; Romany S; Martínez Romero P; Fernández Díaz JA; Fernández Portales J; González Fernández R; Martínez Cáceres G; Merchán Herrera A; Alfonso Manterola F;
    EuroIntervention; 2014 May; 10(1):50-7. PubMed ID: 24832638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential vs. kissing balloon angioplasty for stenting of bifurcation coronary lesions.
    Brueck M; Scheinert D; Flachskampf FA; Daniel WG; Ludwig J
    Catheter Cardiovasc Interv; 2002 Apr; 55(4):461-6. PubMed ID: 11948892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
    Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions.
    Lefèvre T; Ormiston J; Guagliumi G; Schultheiss HP; Quilliet L; Reimers B; Brunel P; Wijns W; Buettner HJ; Hartmann F; Veldhof S; Miquel K; Su X; van der Giessen WJ
    J Am Coll Cardiol; 2005 Aug; 46(4):592-8. PubMed ID: 16098421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome.
    Hoye A; Iakovou I; Ge L; van Mieghem CA; Ong AT; Cosgrave J; Sangiorgi GM; Airoldi F; Montorfano M; Michev I; Chieffo A; Carlino M; Corvaja N; Aoki J; Rodriguez Granillo GA; Valgimigli M; Sianos G; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW; Colombo A
    J Am Coll Cardiol; 2006 May; 47(10):1949-58. PubMed ID: 16697310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.